1. Overview
Glucagon is a peptide hormone secreted by the alpha cells of the pancreatic islets of Langerhans. It plays a critical role in maintaining glucose homeostasis by regulating the metabolism of carbohydrates, fats, and proteins.
The primary physiological function of glucagon is to increase blood glucose levels, especially during fasting or hypoglycemic states. It achieves this by stimulating glucose production and release from the liver. Glucagon and insulin act in a counter-regulatory manner, with insulin lowering blood glucose and glucagon raising it.
Its levels are closely related to catabolic processes and are essential for maintaining energy balance. Due to its metabolic effects, its measurement has important diagnostic utility in various metabolic and endocrine disorders.
2. Symptoms / Clinical Indications
This itself does not directly cause symptoms; however, abnormal glucagon levels are associated with clinical features of glucose imbalance.
Symptom-based indications for glucagon assessment include high blood sugar levels, excessive thirst, and excessive hunger, which may suggest impaired glucose regulation or endocrine dysfunction.
These symptoms are often observed in metabolic disorders such as diabetes mellitus or in rare glucagon-secreting tumors.
3. Mechanism of Action (How Glucagon Works)
It exerts its effects primarily on the liver. When released, it promotes glycogen breakdown (glycogenolysis) and gluconeogenesis, resulting in increased blood glucose availability.
At the same time, glucagon suppresses processes associated with insulin activity. It inhibits glucose uptake by insulin-sensitive cells, suppresses DNA synthesis, reduces glycogen storage in the liver and skeletal muscle, and inhibits protein synthesis.
Conversely, glucagon stimulates fat breakdown (lipolysis) and protein breakdown, supporting energy production during fasting states. Through these actions, glucagon ensures adequate glucose supply to vital organs, particularly the brain, during periods of low carbohydrate intake.
4. Causes and Risk Factors (Assessment-wise Indications)
Assessment of these levels is indicated in several clinical scenarios. In endocrine disorders, testing is used for the evaluation of growth hormone deficiency and adrenal insufficiency.
In metabolic assessment, it assists in the investigation of hypoglycemia and the evaluation of glycogen storage diseases.
The testing also serves as an alternative to the insulin tolerance test for assessing pituitary function when ITT is contraindicated.
In research and specialized endocrine evaluations, it is used in studies of glucose metabolism and hormonal reserve testing.
Persistently elevated levels may indicate glucagonoma, a rare pancreatic alpha-cell tumor, and should be suspected in cases of unexplained hyperglycemia.
5. Prevention, Sample Collection, and Clinical Management
Its testing is primarily a diagnostic tool rather than a preventive measure. Accurate measurement requires strict adherence to sample collection and handling protocols due to the hormone’s instability.
Patients are instructed to stop biotin supplementation for at least 72 hours before testing, as biotin can interfere with immunoassay results. A 1 mL blood sample is collected in an EDTA container. Plasma must be separated promptly, transferred to a plastic transport tube, and frozen immediately. Samples should be transported in a chilled state, and frozen plasma remains stable for up to 7 days.
The normal reference range for plasma glucagon is 13–159 pg/mL, although values may vary depending on the assay used. Laboratories are advised to follow method-specific reference ranges.
It levels normally increase during prolonged fasting and hypoglycemia. Persistently elevated levels may be seen in glucagonoma, liver disease, or other endocrine disorders. Improper sample handling or delayed freezing can result in inaccurate measurements.
Clinically, glucagon estimation supports the diagnosis of metabolic and endocrine disorders, aids in the evaluation of unexplained hyperglycemia, and provides insight into counter-regulatory hormone function. However, results must always be interpreted in conjunction with clinical findings and other laboratory parameters.
